Seminars in Nephrology
Volume 26, Issue 3 , Pages 209-223 , May 2006

Familial Neurohypophyseal Diabetes Insipidus—An Update

  • Jane H. Christensen

      Affiliations

    • Research Unit for Molecular Medicine, Aarhus University Hospital, Skejby Sygehus, Aarhus, Denmark
    • ,
  • Søren Rittig

      Affiliations

    • Department of Pediatrics, Aarhus University Hospital, Skejby Sygehus, Aarhus, Denmark
    • Corresponding Author InformationAddress reprint requests to Søren Rittig, MD, Department of Pediatrics, Aarhus University Hospital, Skejby Sygehus, Brendstrupgaardsvej, DK-8200 Aarhus N, Denmark

References 

  1. Gainer H , Yamashita M , Fields RL , et al.   The magnocellular neuronal phenotype (Cell-specific gene expression in the hypothalamo-neurohypophysial system) . Prog Brain Res . 2002;139:1–14
  2. Murphy D , Wells S . In vivo gene transfer studies on the regulation and function of the vasopressin and oxytocin genes . J Neuroendocrinol . 2003;15:109–125
  3. Mohr E , Richter D . Subcellular vasopressin mRNA trafficking and local translation in dendrites . J Neuroendocrinol . 2004;16:333–339
  4. Breslow E . Structure and folding properties of neurophysin and its peptide complexes (Biological implications) . Regul Pept . 1993;45:15–19
  5. de Bree FM , Burbach JP . Structure-function relationships of the vasopressin prohormone domains . Cell Mol Neurobiol . 1998;18:173–191
  6. de Bree FM . Trafficking of the vasopressin and oxytocin prohormone through the regulated secretory pathway . J Neuroendocrinol . 2000;12:589–594
  7. Burman S , Wellner D , Chait B , et al.   Complete assignment of neurophysin disulfides indicates pairing in two separate domains . Proc Natl Acad Sci U S A . 1989;86:429–433
  8. Ivell R , Schmale H , Richter D . Glycosylation of the arginine vasopressin/neurophysin II common precursor . Biochem Biophys Res Commun . 1981;102:1230–1236
  9. Eubanks S , Nguyen TL , Peyton D , et al.   Modulation of dimerization, binding, stability, and folding by mutation of the neurophysin subunit interface . Biochemistry . 2000;39:8085–8094
  10. de Bree FM , Knight D , Howell L , et al.   Sorting of the vasopressin prohormone into the regulated secretory pathway . FEBS Lett . 2000;475:175–180
  11. Gainer H , Chin H . Molecular diversity in neurosecretion (Reflections on the hypothalamo-neurohypophysial system) . Cell Mol Neurobiol . 1998;18:211–230
  12. Acher R , Chauvet J , Rouille Y . Dynamic processing of neuropeptides (Sequential conformation shaping of neurohypophysial preprohormones during intraneuronal secretory transport) . J Mol Neurosci . 2002;18:223–228
  13. Ward DT , Hammond TG , Harris HW . Modulation of vasopressin-elicited water transport by trafficking of aquaporin2-containing vesicles . Annu Rev Physiol . 1999;61:683–697
  14. Fujiwara TM , Bichet DG . Molecular biology of hereditary diabetes insipidus . J Am Soc Nephrol . 2005;16:2836–2846
  15. Christensen JH , Siggaard C , Corydon TJ , et al.   Six novel mutations in the arginine vasopressin gene in 15 kindreds with autosomal dominant familial neurohypophyseal diabetes insipidus give further insight into the pathogenesis . Eur J Hum Genet . 2004;12:44–51
  16. Willcutts MD , Felner E , White PC . Autosomal recessive familial neurohypophyseal diabetes insipidus with continued secretion of mutant weakly active vasopressin . Hum Mol Genet . 1999;8:1303–1307
  17. Forssman H . On hereditary diabetes insipidus with special regard to a sex-linked form . Acta Med Scand . 1945;159(suppl):1–196
  18. Robertson GL , Kopp P , Rittig S , et al.   Rediscovery of Swedish kindred with x-linked ‘vasopressin-responsive’ diabetes insipidus (Validation and explanation of the unusual clinical phenotype) . 2004; Presented at the Fifth Global Conference of the NDI Foundation, Phoenix, AZ, April 10, (http://www.ndif.org/conf04/pab-Robertson04.html)
  19. Hansen LK , Rittig S , Robertson GL . Genetic basis of familial neurohypophyseal diabetes insipidus . Trends Endocrinol Metab . 1997;8:363–372
  20. Habiby RL , Robertson GL , Kaplowitz PB , et al.   A novel X-linked form of familial neurohypophyseal diabetes insipidus . J Invest Med . 1996;44:388A; (abstr)
  21. Riddell DC , Mallonee R , Phillips JA , et al.   Chromosomal assignment of human sequences encoding arginine vasopressin-neurophysin II and growth hormone releasing factor . Somat Cell Mol Genet . 1985;11:189–195
  22. Summar ML , Phillips JA , Battey J , et al.   Linkage relationships of human arginine vasopressin-neurophysin-II and oxytocin-neurophysin-I to prodynorphin and other loci on chromosome 20 . Mol Endocrinol . 1990;4:947–950
  23. Rao VV , Loffler C , Battey J , et al.   The human gene for oxytocin-neurophysin I (OXT) is physically mapped to chromosome 20p13 by in situ hybridization . Cytogenet Cell Genet . 1992;61:271–273
  24. Land H , Schutz G , Schmale H , et al.   Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin-neurophysin II precursor . Nature . 1982;295:299–303
  25. Sausville E , Carney D , Battey J . The human vasopressin gene is linked to the oxytocin gene and is selectively expressed in a cultured lung cancer cell line . J Biol Chem . 1985;260:10236–10241
  26. Gainer H , Fields RL , House SB . Vasopressin gene expression (Experimental models and strategies) . Exp Neurol . 2001;171:190–199
  27. Ivell R , Richter D . Structure and comparison of the oxytocin and vasopressin genes from rat . Proc Natl Acad Sci U S A . 1984;81:2006–2010
  28. Morello JP , Bichet DG . Nephrogenic diabetes insipidus . Annu Rev Physiol . 2001;63:607–630
  29. Figueroa J , Morley SD , Heierhorst J , et al.   Two isotocin genes are present in the white sucker Catostomus commersoni both lacking introns in their protein coding regions . EMBO J . 1989;8:2873–2877
  30. Heierhorst J , Lederis K , Richter D . Presence of a member of the Tc1-like transposon family from nematodes and Drosophila within the vasotocin gene of a primitive vertebrate, the Pacific hagfish Eptatretus stouti . Proc Natl Acad Sci U S A . 1992;89:6798–6802
  31. Hyodo S , Ishii S , Joss JM . Australian lungfish neurohypophysial hormone genes encode vasotocin and [Phe2]mesotocin precursors homologous to tetrapod-type precursors . Proc Natl Acad Sci U S A . 1997;94:13339–13344
  32. Burbach JP , Luckman SM , Murphy D , et al.   Gene regulation in the magnocellular hypothalamo-neurohypophysial system . Physiol Rev . 2001;81:1197–1267
  33. Acher R . Neurohypophysial peptide systems (Processing machinery, hydroosmotic regulation, adaptation and evolution) . Regul Pept . 1993;45:1–13
  34. Hoyle CH . Neuropeptide families (Evolutionary perspectives) . Regul Pept . 1998;73:1–33
  35. Acher R . Molecular evolution of biologically active polypeptides . Proc R Soc Lond B Biol Sci . 1980;210:21–43
  36. Glasgow E , Kusano K , Chin H , et al.   Single cell reverse transcription-polymerase chain reaction analysis of rat supraoptic magnocellular neurons (Neuropeptide phenotypes and high voltage-gated calcium channel subtypes) . Endocrinology . 1999;140:5391–5401
  37. Xi D , Kusano K , Gainer H . Quantitative analysis of oxytocin and vasopressin messenger ribonucleic acids in single magnocellular neurons isolated from supraoptic nucleus of rat hypothalamus . Endocrinology . 1999;140:4677–4682
  38. Gainer H . Cell-specific gene expression in oxytocin and vasopressin magnocellular neurons . Adv Exp Med Biol . 1998;449:15–27
  39. Fields RL , House SB , Gainer H . Regulatory domains in the intergenic region of the oxytocin and vasopressin genes that control their hypothalamus-specific expression in vitro . J Neurosci . 2003;23:7801–7809
  40. Chen LQ , Rose JP , Breslow E , et al.   Crystal structure of a bovine neurophysin II dipeptide complex at 2.8 A determined from the single-wavelength anomalous scattering signal of an incorporated iodine atom . Proc Natl Acad Sci U S A . 1991;88:4240–4244
  41. Barat C , Simpson L , Breslow E . Properties of human vasopressin precursor constructs (Inefficient monomer folding in the absence of copeptin as a potential contributor to diabetes insipidus) . Biochemistry . 2004;43:8191–8203
  42. Sitia R , Braakman I . Quality control in the endoplasmic reticulum protein factory . Nature . 2003;426:891–894
  43. Lee MC , Miller EA , Goldberg J , et al.   Bi-directional protein transport between the ER and Golgi . Annu Rev Cell Dev Biol . 2004;20:87–123
  44. Romisch K . Endoplasmic reticulum-associated degradation . Annu Rev Cell Dev Biol . 2005;21:435–456
  45. Arvan P , Castle D . Sorting and storage during secretory granule biogenesis (Looking backward and looking forward) . Biochem J . 1998;332:593–610
  46. Gerdes HH , Rosa P , Phillips E , et al.   The primary structure of human secretogranin II, a widespread tyrosine-sulfated secretory granule protein that exhibits low pH- and calcium-induced aggregation . J Biol Chem . 1989;264:12009–12015
  47. Chanat E , Huttner WB . Milieu-induced, selective aggregation of regulated secretory proteins in the trans-Golgi network . J Cell Biol . 1991;115:1505–1519
  48. Zhang BJ , Yamashita M , Fields R , et al.   EGFP-tagged vasopressin precursor protein sorting into large dense core vesicles and secretion from PC12 cells . Cell Mol Neurobiol . 2005;25:581–605
  49. de Bree FM , Van Der Kleij AA , Nijenhuis M , et al.   The hormone domain of the vasopressin prohormone is required for the correct prohormone trafficking through the secretory pathway . J Neuroendocrinol . 2003;15:1156–1163
  50. Gainer H . Mechanisms of intracellular trafficking and processing of pro-proteins . In:  Loh YP editors. Intracellular Protein Trafficking and Proprotein Processing (An Overview) . Boca Raton, FL: CRC Press; 1993;p. 1–17
  51. Seidah NG , Gaspar L , Mion P , et al.   cDNA sequence of two distinct pituitary proteins homologous to Kex2 and furin gene products (Tissue-specific mRNAs encoding candidates for pro-hormone processing proteinases) . DNA Cell Biol . 1990;9:415–424
  52. Gainer H , Sarne Y , Brownstein MJ . Neurophysin biosynthesis (Conversion of a putative precursor during axonal transport) . Science . 1977;195:1354–1356
  53. Breslow E , Burman S . Molecular, thermodynamic, and biological aspects of recognition and function in neurophysin-hormone systems (A model system for the analysis of protein-peptide interactions) . Adv Enzymol Relat Areas Mol Biol . 1990;63:1–67
  54. Tae HJ , Baek KH , Shim SM , et al.   A novel splice site mutation of the arginine vasopressin-neurophysin II gene identified in a kindred with autosomal dominant familial neurohypophyseal diabetes insipidus . Mol Genet Metab . 2005;86:307–313
  55. Rittig S , Robertson GL , Siggaard C , et al.   Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus . Am J Hum Genet . 1996;58:107–117
  56. Ye L , Li X , Chen Y , et al.   Autosomal dominant neurohypophyseal diabetes insipidus with linkage to chromosome 20p13 but without mutations in the AVP-NPII Gene . J Clin Endocrinol Metab . 2005;90:4388–4393
  57. Abbes AP , Bruggeman B , van den Akker EL , et al.   Identification of two distinct mutations at the same nucleotide position, concomitantly with a novel polymorphism in the vasopressin-neurophysin II gene (AVP-NP II) in two Dutch families with familial neurohypophyseal diabetes insipidus . Clin Chem . 2000;46:1699–1702
  58. Robertson GL , Rittig S , Gu WX , et al.   Pathogenesis and pathophysiology of familial neurohypophyseal diabetes insipidus . In:  Saito T ,  Kurokawa K ,  Yoshida S editor. Neurohypophysis (Recent Progress of Vasopressin and Oxytocin Research) . Amsterdam: Elsevier Science B.V; 1995;p. 593–603
  59. Ito M , Jameson JL . Molecular basis of autosomal dominant neurohypophyseal diabetes insipidus (Cellular toxicity caused by the accumulation of mutant vasopressin precursors within the endoplasmic reticulum) . J Clin Invest . 1997;99:1897–1905
  60. Ito M , Yu RN , Jameson JL . Mutant vasopressin precursors that cause autosomal dominant neurohypophyseal diabetes insipidus retain dimerization and impair the secretion of wild-type proteins . J Biol Chem . 1999;274:9029–9037
  61. Davies J , Murphy D . Autophagy in hypothalamic neurones of rats expressing a familial neurohypophysial diabetes insipidus transgene . J Neuroendocrinol . 2002;14:629–637
  62. Breslow E , Walter R . Binding properties of bovine neurophysins I and II (An equilibrium dialysis study) . Mol Pharmacol . 1972;8:75–81
  63. Ando S , McPhie P , Chaiken IM . Sequence redesign and the assembly mechanism of the oxytocin/bovine neurophysin I biosynthetic precursor . J Biol Chem . 1987;262:12962–12969
  64. Deeb R , Breslow E . Thermodynamic role of the pro region of the neurophysin precursor in neurophysin folding (Evidence from the effects of ligand peptides on folding) . Biochemistry . 1996;35:864–873
  65. Breslow E , Mombouyran V , Deeb R , et al.   Structural basis of neurophysin hormone specificity (Geometry, polarity, and polarizability in aromatic ring interactions) . Protein Sci . 1999;8:820–831
  66. Eubanks S , Lu M , Peyton D , et al.   Expression, folding, and thermodynamic properties of the bovine oxytocin-neurophysin precursor (Relationships to the intermolecular oxytocin-neurophysin complex) . Biochemistry . 1999;38:13530–13541
  67. Nguyen TL , Breslow E . NMR analysis of the monomeric form of a mutant unliganded bovine neurophysin (Comparison with the crystal structure of a neurophysin dimer) . Biochemistry . 2002;41:5920–5930
  68. Naik MT , Lee H , Bracken C , et al.   NMR investigation of main-chain dynamics of the H80E mutant of bovine neurophysin-I (Demonstration of dimerization-induced changes at the hormone-binding site) . Biochemistry . 2005;44:11766–11776
  69. Rose JP , Wu CK , Hsiao CD , et al.   Crystal structure of the neurophysin-oxytocin complex . Nat Struct Biol . 1996;3:163–169
  70. Wu CK , Hu B , Rose JP , et al.   Structures of an unliganded neurophysin and its vasopressin complex (Implications for binding and allosteric mechanisms) . Protein Sci . 2001;10:1869–1880
  71. Huang HB , Breslow E . Identification of the unstable neurophysin disulfide and localization to the hormone-binding site (Relationship to folding-unfolding pathways) . J Biol Chem . 1992;267:6750–6756
  72. Kanmera T , Chaiken IM . Molecular properties of the oxytocin/bovine neurophysin biosynthetic precursor (Studies using a semisynthetic precursor) . J Biol Chem . 1985;260:8474–8482
  73. Fassina G , Chaiken IM . Structural requirements of peptide hormone binding for peptide-potentiated self-association of bovine neurophysin II . J Biol Chem . 1988;263:13539–13543
  74. Nicolas P , Wolff J , Camier M , et al.   Importance of neurophysin dimer and of tyrosine-49 in the binding of neurohypophyseal peptides . J Biol Chem . 1978;253:2633–2639
  75. Eubanks S , Nguyen TL , Deeb R , et al.   Effects of diabetes insipidus mutations on neurophysin folding and function . J Biol Chem . 2001;276:29671–29680
  76. Hanhart E . Die erbpathologie des diabetes insipidus . In: in Handbuch der Erbbiologie des Menschen . Berlin: Julius Springer; 1940;p. 798–823
  77. Gaupp R . Über den diabetes insipidus . Z ges Neurol Psychiat . 1941;171:514–546
  78. Green JR , Buchan GC , Alvord ECJ , et al.   Hereditary and idiopathic types of diabetes insipidus . Brain . 1967;90:707–714
  79. Braverman LE , Mancini JP , McGoldrick DM . Hereditary idiopathic diabetes insipidus (A case report with autopsy findings) . Ann Intern Med . 1965;63:503–508
  80. Bergeron C , Kovacs K , Ezrin C , et al.   Hereditary diabetes insipidus (An immunohistochemical study of the hypothalamus and pituitary gland) . Acta Neuropathol . 1991;81:345–348
  81. McLeod JF , Kovacs L , Gaskill MB , et al.   Familial neurohypophyseal diabetes insipidus associated with a signal peptide mutation . J Clin Endocrinol Metab . 1993;77:599A–599G
  82. Friberg MA , Spiess M , Rutishauser J . Degradation of wild-type vasopressin precursor and pathogenic mutants by the proteasome . J Biol Chem . 2004;279:19441–19447
  83. Siggaard C , Christensen JH , Corydon TJ , et al.   Expression of three different mutations in the arginine vasopressin gene suggests genotype-phenotype correlation in familial neurohypophyseal diabetes insipidus kindreds . Clin Endocrinol (Oxf) . 2005;63:207–216
  84. Miyamoto S , Sasaki N , Tanabe Y . Magnetic resonance imaging in familial central diabetes insipidus . Neuroradiology . 1991;33:272–273
  85. Kubota T , Yamamoto T , Ozono K , et al.   Hyperintensity of posterior pituitary on MR T1WI in a boy with central diabetes insipidus caused by missense mutation of neurophysin II gene . Endocr J . 2001;48:459–463
  86. Mahoney CP , Weinberger E , Bryant C , et al.   Effects of aging on vasopressin production in a kindred with autosomal dominant neurohypophyseal diabetes insipidus due to the DeltaE47 neurophysin mutation . J Clin Endocrinol Metab . 2002;87:870–876
  87. Olias G , Richter D , Schmale H . Heterologous expression of human vasopressin-neurophysin precursors in a pituitary cell line (Defective transport of a mutant protein from patients with familial diabetes insipidus) . DNA Cell Biol . 1996;15:929–935
  88. Beuret N , Rutishauser J , Bider MD , et al.   Mechanism of endoplasmic reticulum retention of mutant vasopressin precursor caused by a signal peptide truncation associated with diabetes insipidus . J Biol Chem . 1999;274:18965–18972
  89. Siggaard C , Rittig S , Corydon TJ , et al.   Clinical and molecular evidence of abnormal processing and trafficking of the vasopressin preprohormone in a large kindred with familial neurohypophyseal diabetes insipidus due to a signal peptide mutation . J Clin Endocrinol Metab . 1999;84:2933–2941
  90. Nijenhuis M , Zalm R , Burbach JP . Mutations in the vasopressin prohormone involved in diabetes insipidus impair endoplasmic reticulum export but not sorting . J Biol Chem . 1999;274:21200–21208
  91. Nijenhuis M , Zalm R , Burbach JP . A diabetes insipidus vasopressin prohormone altered outside the central core of neurophysin accumulates in the endoplasmic reticulum . Mol Cell Endocrinol . 2000;167:55–67
  92. Nijenhuis M , van den Akker EL , Zalm R , et al.   Familial neurohypophysial diabetes insipidus in a large Dutch kindred (Effect of the onset of diabetes on growth in children and cell biological defects of the mutant vasopressin prohormone) . J Clin Endocrinol Metab . 2001;86:3410–3420
  93. Christensen JH , Siggaard C , Corydon TJ , et al.   Impaired trafficking of mutated AVP prohormone in cells expressing rare disease genes causing autosomal dominant familial neurohypophyseal diabetes insipidus . Clin Endocrinol (Oxf) . 2004;60:125–136
  94. Christensen JH , Siggaard C , Corydon TJ , et al.   Differential cellular handling of defective arginine vasopressin (AVP) prohormones in cells expressing mutations of the AVP gene associated with autosomal dominant and recessive familial neurohypophyseal diabetes insipidus . J Clin Endocrinol Metab . 2004;89:4521–4531
  95. Russell TA , Ito M , Ito M , et al.   A murine model of autosomal dominant neurohypophyseal diabetes insipidus reveals progressive loss of vasopressin-producing neurons . J Clin Invest . 2003;112:1697–1706
  96. Si-Hoe S , de Bree FM , Nijenhuis M , et al.   Endoplasmic reticulum derangement in hypothalamic neurons of rats expressing a familial neurohypophyseal diabetes insipidus mutant vasopressin transgene . FASEB J . 2000;14:1680–1684
  97. Castino R , Davies J , Beaucourt S , et al.   Autophagy is a prosurvival mechanism in cells expressing an autosomal dominant familial neurohypophyseal diabetes insipidus mutant vasopressin transgene . FASEB J . 2005;19:1021–1023
  98. Castino R , Isidoro C , Murphy D . Autophagy-dependent cell survival and cell death in an autosomal dominant familial neurohypophyseal diabetes insipidus in vitro model . FASEB J . 2005;19:1024–1026
  99. Callea F , Brisigotti M , Fabbretti G , et al.   Hepatic endoplasmic reticulum storage diseases . Liver . 1992;12:357–362
  100. Kim PS , Arvan P . Endocrinopathies in the family of endoplasmic reticulum (ER) storage diseases (Disorders of protein trafficking and the role of ER molecular chaperones) . Endocr Rev . 1998;19:173–202
  101. Medeiros-Neto G , Kim PS , Yoo SE , et al.   Congenital hypothyroid goiter with deficient thyroglobulin (Identification of an endoplasmic reticulum storage disease with induction of molecular chaperones) . J Clin Invest . 1996;98:2838–2844
  102. Lamande SR , Chessler SD , Golub SB , et al.   Endoplasmic reticulum-mediated quality control of type I collagen production by cells from osteogenesis imperfecta patients with mutations in the pro alpha 1 (I) chain carboxyl-terminal propeptide which impair subunit assembly . J Biol Chem . 1995;270:8642–8649
  103. Lehrman MA , Schneider WJ , Brown MS , et al.   The Lebanese allele at the low density lipoprotein receptor locus (Nonsense mutation produces truncated receptor that is retained in endoplasmic reticulum) . J Biol Chem . 1987;262:401–410
  104. Jensen HK , Holst H , Jensen LG , et al.   A common W556S mutation in the LDL receptor gene of Danish patients with familial hypercholesterolemia encodes a transport-defective protein . Atherosclerosis . 1997;131:67–72
  105. Jorgensen MM , Jensen ON , Holst HU , et al.   Grp78 is involved in retention of mutant low density lipoprotein receptor protein in the endoplasmic reticulum . J Biol Chem . 2000;275:33861–33868
  106. Rittig S , Siggaard C , Ozata M , et al.   Autosomal dominant neurohypophyseal diabetes insipidus due to substitution of histidine for tyrosine(2) in the vasopressin moiety of the hormone precursor . J Clin Endocrinol Metab . 2002;87:3351–3355
  107. Wahlstrom JT , Fowler MJ , Nicholson WE , et al.   A novel mutation in the preprovasopressin gene identified in a kindred with autosomal dominant neurohypophyseal diabetes insipidus . J Clin Endocrinol Metab . 2004;89:1963–1968
  108. Blumenstein M , Hruby VJ . Interactions of oxytocin with bovine neurophysins I and II (Use of 13C nuclear magnetic resonance and hormones specifically enriched with 13C in the glycinamide-9 and half-cystine-1 positions) . Biochemistry . 1977;16:5169–5177
  109. Lacombe U . De la polydipsie (L’experiance) . J Med Chir . 1841;7:323–339
  110. Weil A . Ueber die hereditaere Form des Diabetes insipidus . Virchows Arch Path Anat . 1884;95:70–95
  111. McIlraith CH . Notes on some cases of diabetes insipidus with marked family and hereditary tendencies . Lancet . 1892;ii:767–768
  112. Elias PC , Elias LL , Torres N , et al.   Progressive decline of vasopressin secretion in familial autosomal dominant neurohypophyseal diabetes insipidus presenting a novel mutation in the vasopressin-neurophysin II gene . Clin Endocrinol (Oxf) . 2003;59:511–518
  113. Rutishauser J , Boni-Schnetzler M , Boni J , et al.   A novel point mutation in the translation initiation codon of the pre- pro-vasopressin-neurophysin II gene (cosegregation with morphological abnormalities and clinical symptoms in autosomal dominant neurohypophyseal diabetes insipidus) . J Clin Endocrinol Metab . 1996;81:192–198
  114. Heppner C , Kotzka J , Bullmann C , et al.   Identification of mutations of the arginine vasopressin-neurophysin II gene in two kindreds with familial central diabetes insipidus . J Clin Endocrinol Metab . 1998;83:693–696
  115. Repaske DR , Medlej R , Gultekin EK , et al.   Heterogeneity in clinical manifestation of autosomal dominant neurohypophyseal diabetes insipidus caused by a mutation encoding Ala-1- ->Val in the signal peptide of the arginine vasopressin/neurophysin II/copeptin precursor . J Clin Endocrinol Metab . 1997;82:51–56
  116. Durr JA . Diabetes insipidus in pregnancy . Am J Kidney Dis . 1987;9:276–283
  117. Robertson GL . Differential diagnosis of polyuria . Annu Rev Med . 1988;39:425–442
  118. Tajima T , Nakae J , Takekoshi Y , et al.   Three novel AVPR2 mutations in three Japanese families with X-linked nephrogenic diabetes insipidus . Pediatr Res . 1996;39:522–526
  119. Sadeghi H , Robertson GL , Bichet DG , et al.   Biochemical basis of partial nephrogenic diabetes insipidus phenotypes . Mol Endocrinol . 1997;11:1806–1813
  120. Vargas-Poussou R , Forestier L , Dautzenberg MD , et al.   Mutations in the vasopressin V2 receptor and aquaporin-2 genes in 12 families with congenital nephrogenic diabetes insipidus . J Am Soc Nephrol . 1997;8:1855–1862
  121. Pasel K , Schulz A , Timmermann K , et al.   Functional characterization of the molecular defects causing nephrogenic diabetes insipidus in eight families . J Clin Endocrinol Metab . 2000;85:1703–1710
  122. Inaba S , Hatakeyama H , Taniguchi N , et al.   The property of a novel v2 receptor mutant in a patient with nephrogenic diabetes insipidus . J Clin Endocrinol Metab . 2001;86:381–385
  123. Rittig S , Faerch M , Christensen JH , et al.   Clinical phenotype and molecular characterization of a mutant V2 receptor associated with partial congenital nephrogenic diabetes insipidus . 2004; Presented at the Fifth Global Conference of the NDI Foundation, Phoenix, AZ, April 10, (http://www.ndif.org/conf04/pab-Rittig04.html)
  124. Mizuno H , Sugiyama Y , Ohro Y , et al.   Clinical characteristics of eight patients with congenital nephrogenic diabetes insipidus . Endocrine . 2004;24:55–59
  125. Bruins J , Kovacs GL , Abbes AP , et al.   Minor disturbances in central nervous system function in familial neurohypophysial diabetes insipidus . Psychoneuroendocrinology . 2006;31:80–91
  126. Ghirardello S , Malattia C , Scagnelli P , et al.   Current perspective on the pathogenesis of central diabetes insipidus . J Pediatr Endocrinol Metab . 2005;18:631–645
  127. Rutishauser J , Kopp P , Gaskill MB , et al.   Clinical and molecular analysis of three families with autosomal dominant neurohypophyseal diabetes insipidus associated with a novel and recurrent mutations in the vasopressin-neurophysin II gene . Eur J Endocrinol . 2002;146:649–656
  128. Fukuda I , Hizuka N , Takano K . Oral DDAVP is a good alternative therapy for patients with central diabetes insipidus (Experience of five-year treatment) . Endocr J . 2003;50:437–443
  129. Rittig S , Jensen AR , Jensen KT , et al.   Effect of food intake on the pharmacokinetics and antidiuretic activity of oral desmopressin (DDAVP) in hydrated normal subjects . Clin Endocrinol (Oxf) . 1998;48:235–241
  130. Bogaert G , Vande Walle J , Mattson S , et al.   A pharmacodynamic study in children with primary nocturnal enuresis using a new “melt” orodispersible formulation of desmopressin . Neurourol Urodyn . 2005;24:578–579 (abstr)
  131. Geddes BJ , Harding TC , Lightman SL , et al.   Long-term gene therapy in the CNS (Reversal of hypothalamic diabetes insipidus in the Brattleboro rat by using an adenovirus expressing arginine vasopressin) . Nat Med . 1997;3:1402–1404
  132. Ideno J , Mizukami H , Honda K , et al.   Persistent phenotypic correction of central diabetes insipidus using adeno-associated virus vector expressing arginine-vasopressin in brattleboro rats . Mol Ther . 2003;8:895–902
  133. Bienemann AS , Martin-Rendon E , Cosgrave AS , et al.   Long-term replacement of a mutated nonfunctional CNS gene (Reversal of hypothalamic diabetes insipidus using an EIAV-based lentiviral vector expressing arginine vasopressin) . Mol Ther . 2003;7:588–596
  134. Yoshida M , Iwasaki Y , Asai M , et al.   Gene therapy for central diabetes insipidus (Effective antidiuresis by muscle-targeted gene transfer) . Endocrinology . 2004;145:261–268
  135. Schwarz ER , Sanghi P . Conivaptan (A selective vasopressin antagonist for the treatment of heart failure) . Expert Rev Cardiovasc Ther . 2006;4:17–23
  136. Ito M , Oiso Y , Murase T , et al.   Possible involvement of inefficient cleavage of preprovasopressin by signal peptidase as a cause for familial central diabetes insipidus . J Clin Invest . 1993;91:2565–2571
  137. Rittig S , Kovacs L , Gregersen N , et al.   Familial neurogenic diabetes insipidus in 5 Danish kindreds . In:  Gross P ,  Richter D ,  Robertson GL editor. Vasopressin . Paris: John Libbey Eurotext; 1993;p. 600
  138. Repaske DR , Summar ML , Krishnamani MR , et al.   Recurrent mutations in the vasopressin-neurophysin II gene cause autosomal dominant neurohypophyseal diabetes insipidus . J Clin Endocrinol Metab . 1996;81:2328–2334
  139. Calvo B , Bilbao JR , Urrutia I , et al.   Identification of a novel nonsense mutation and a missense substitution in the vasopressin-neurophysin II gene in two Spanish kindreds with familial neurohypophyseal diabetes insipidus . J Clin Endocrinol Metab . 1998;83:995–997
  140. Boson WL , Sarubi JC , D’Alva CB , et al.   A signal peptide mutation of the arginine vasopressin gene in monozygotic twins . Clin Endocrinol (Oxf) . 2003;58:108–110
  141. Kanemitsu N , Kawauchi A , Nishida M , et al.   Familial central diabetes insipidus detected by nocturnal enuresis . Pediatr Nephrol . 2002;17:1063–1065
  142. Bahnsen U , Oosting P , Swaab DF , et al.   A missense mutation in the vasopressin-neurophysin precursor gene cosegregates with human autosomal dominant neurohypophyseal diabetes insipidus . EMBO J . 1992;11:19–23
  143. Goking NQ , Chertow BS , Robertson GL , et al.   A novel AVP-neurophysin gene mutation in familial neurohypophyseal diabetes insipidus presenting with nocturnal enuresis . J Endocrine Genetics . 2001;2:105–113
  144. Calvo B , Bilbao JR , Rodriguez A , et al.   Molecular analysis in familial neurohypophyseal diabetes insipidus (Early diagnosis of an asymptomatic carrier) . J Clin Endocrinol Metab . 1999;84:3351–3354
  145. Gagliardi PC , Bernasconi S , Repaske DR . Autosomal dominant neurohypophyseal diabetes insipidus associated with a missense mutation encoding Gly23–>Val in neurophysin II . J Clin Endocrinol Metab . 1997;82:3643–3646
  146. Repaske DR , Browning JE . A de novo mutation in the coding sequence for neurophysin-II (Pro24– >Leu) is associated with onset and transmission of autosomal dominant neurohypophyseal diabetes insipidus . J Clin Endocrinol Metab . 1994;79:421–427
  147. Wolf MT , Dotsch J , Metzler M , et al.   A new missense mutation of the vasopressin-neurophysin II gene in a family with neurohypophyseal diabetes insipidus . Horm Res . 2003;60:143–147
  148. Skordis N , Patsalis PC , Hettinger JA , et al.   A novel arginine vasopressin-neurophysin II mutation causes autosomal dominant neurohypophyseal diabetes insipidus and morphologic pituitary changes . Horm Res . 2000;53:239–245
  149. Fluck CE , Deladoey J , Nayak S , et al.   Autosomal dominant neurohypophyseal diabetes insipidus in a Swiss family, caused by a novel mutation (C59Delta/A60W) in the neurophysin moiety of prepro-vasopressin-neurophysin II (AVP-NP II) . Eur J Endocrinol . 2001;145:439–444
  150. Yuasa H , Ito M , Nagasaki H , et al.   Glu-47, which forms a salt bridge between neurophysin-II and arginine vasopressin, is deleted in patients with familial central diabetes insipidus . J Clin Endocrinol Metab . 1993;77:600–604
  151. Miyakoshi M , Kamoi K , Murase T , et al.   Novel mutant vasopressin-neurophysin II gene associated with familial neurohypophyseal diabetes insipidus . Endocr J . 2004;51:551–556
  152. Grant FD , Ahmadi A , Hosley CM , et al.   Two novel mutations of the vasopressin gene associated with familial diabetes insipidus and identification of an asymptomatic carrier infant . J Clin Endocrinol Metab . 1998;83:3958–3964
  153. Ito M , Mori Y , Oiso Y , et al.   A single base substitution in the coding region for neurophysin II associated with familial central diabetes insipidus . J Clin Invest . 1991;87:725–728
  154. Bullmann C , Kotzka J , Grimm T , et al.   Identification of a novel mutation in the arginine vasopressin-neurophysin II gene in familial central diabetes insipidus . Exp Clin Endocrinol Diabetes . 2002;110:134–137
  155. Nagasaki H , Ito M , Yuasa H , et al.   Two novel mutations in the coding region for neurophysin-II associated with familial central diabetes insipidus . J Clin Endocrinol Metab . 1995;80:1352–1356
  156. Rauch F , Lenzner C , Nurnberg P , et al.   A novel mutation in the coding region for neurophysin-II is associated with autosomal dominant neurohypophyseal diabetes insipidus . Clin Endocrinol (Oxf) . 1996;44:45–51
  157. Ueta Y , Taniguchi S , Yoshida A , et al.   A new type of familial central diabetes insipidus caused by a single base substitution in the neurophysin II coding region of the vasopressin gene . J Clin Endocrinol Metab . 1996;81:1787–1790
  158. Rutishauser J , Kopp P , Gaskill MB , et al.   A novel mutation (R97C) in the neurophysin moiety of prepro-vasopressin-neurophysin II associated with autosomal-dominant neurohypophyseal diabetes insipidus . Mol Genet Metab . 1999;67:89–92
  159. Mundschenk J , Rittig S , Siggaard C , et al.   A new mutation of the arginine vasopressin-neurophysin II gene in a family with autosomal dominant neurohypophyseal diabetes insipidus . Exp Clin Endocrinol Diabetes . 2001;109:406–409
  160. DiMeglio LA , Gagliardi PC , Browning JE , et al.   A missense mutation encoding cys(67) –> gly in neurophysin II is associated with early onset autosomal dominant neurohypophyseal diabetes insipidus . Mol Genet Metab . 2001;72:39–44
  161. Baglioni S , Corona G , Maggi M , et al.   Identification of a novel mutation in the arginine vasopressin-neurophysin II gene affecting the sixth intrachain disulfide bridge of the neurophysin II moiety . Eur J Endocrinol . 2004;151:605–611
  162. Davies JH , Penney M , Abbes AP , et al.   Clinical features, diagnosis and molecular studies of familial central diabetes insipidus . Horm Res . 2005;64:231–237
  163. Santiprabhob J , Browning J , Repaske D . A missense mutation encoding Cys73Phe in neurophysin II is associated with autosomal dominant neurohypophyseal diabetes insipidus . Mol Genet Metab . 2002;77:112–118
  164. Fujii H , Iida S , Moriwaki K . Familial neurohypophyseal diabetes insipidus associated with a novel mutation in the vasopressin-neurophysin II gene . Int J Mol Med . 2000;5:229–234
  165. van den Akker EL , de Groot MR , Abbes AP , et al.   [Identification of a new mutation (CysII6Gly) in a family with neurogenic diabetes insipidus.] . Ned Tijdschr Geneeskd . 2000;144:941–945
  166. den Dunnen JT , Antonarakis SE . Mutation nomenclature extensions and suggestions to describe complex mutations (A discussion) . Hum Mutat . 2000;15:7–12

 Supported in part by the Institute of Clinical Medicine, Aarhus University; the Karen Elise Jensen Foundation; and the Novo Nordisk Foundation.

PII: S0270-9295(06)00030-1

doi: 10.1016/j.semnephrol.2006.03.003

Seminars in Nephrology
Volume 26, Issue 3 , Pages 209-223 , May 2006

Article Tools

* Image Usage & Resolution